Pictet Asset Management’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.7M | Buy |
1,265,754
+17,033
| +1% | +$238K | 0.02% | 537 |
|
|
2025
Q1 | $16.8M | Hold |
1,248,721
| – | – | 0.02% | 538 |
|
|
2024
Q4 | $23.9M | Buy |
1,248,721
+223,384
| +22% | +$4.28M | 0.03% | 453 |
|
|
2024
Q3 | $23.3M | Buy |
1,025,337
+3,233
| +0.3% | +$73.6K | 0.03% | 450 |
|
|
2024
Q2 | $13.3M | Sell |
1,022,104
-73,337
| -7% | -$954K | 0.02% | 571 |
|
|
2024
Q1 | $19.2M | Buy |
1,095,441
+44,565
| +4% | +$780K | 0.02% | 502 |
|
|
2023
Q4 | $22.9M | Sell |
1,050,876
-15,467
| -1% | -$337K | 0.03% | 452 |
|
|
2023
Q3 | $16.4M | Buy |
+1,066,343
| New | +$16.4M | 0.02% | 510 |
|